Google Play app · Medical
LibreLinkUp
by Newyu, Inc
LibreLinkUp is a medical app by Newyu, Inc on Google Play and an average rating of 4.1. On September 27, 2026 it ranked #24 in the Top Free Medical chart in Spain, and it appears in 27 Top Free charts across 27 countries.
Full analysis: keywords, competitors, adsGoogle Play ↗
Key facts
- Developer
- Newyu, Inc
- Category
- Medical
- Installs
- —
- Rating
- ★ 4.1 / 5
- Ratings
- —
- First released
- —
- Tracked by ASO Lab since
- September 25, 2026
- Package
org.nativescript.LibreLinkUp
Top Free ranks by country
| Country | Chart | Rank |
|---|---|---|
| Spain | Top Free · Medical | #24 |
| Portugal | Top Free · Medical | #24 |
| United Kingdom | Top Free · Medical | #25 |
| Canada | Top Free · Medical | #31 |
| United Arab Emirates | Top Free · Medical | #33 |
| Australia | Top Free · Medical | #37 |
| Colombia | Top Free · Medical | #40 |
| Italy | Top Free · Medical | #40 |
| Mexico | Top Free · Medical | #40 |
| Turkey | Top Free · Medical | #40 |
| Saudi Arabia | Top Free · Medical | #48 |
| Argentina | Top Free · Medical | #54 |
| France | Top Free · Medical | #56 |
| Netherlands | Top Free · Medical | #62 |
| United States | Top Free · Medical | #72 |
| Brazil | Top Free · Medical | #75 |
| Israel | Top Free · Medical | #77 |
| Germany | Top Free · Medical | #79 |
| Singapore | Top Free · Medical | #82 |
| Finland | Top Free · Medical | #84 |
| Chile | Top Free · Medical | #85 |
| Denmark | Top Free · Medical | #86 |
| Ireland | Top Free · Medical | #86 |
| Norway | Top Free · Medical | #86 |
| Austria | Top Free · Medical | #87 |
| Japan | Top Free · Medical | #97 |
| Egypt | Top Free · Medical | #98 |
Rating and installs history
History for this app starts building from the first day we track it.
Apps ranked near LibreLinkUp
More apps by Newyu, Inc
About this data
Figures come from the public Google Play listing and the Top Free charts that ASO Lab saves every day. Install numbers are the ranges Google Play shows, not exact counts. For keyword positions, competitors and ad campaigns, open the full analysis.